BANK VONTOBEL/CALL/YPSOMED N/340/0.02/20.12.24 Share Price

Warrant

WYPAJV

CH1312989580

Market Closed - Swiss Exchange 16:20:00 01/07/2024 BST
1.69 CHF +2.42% Intraday chart for BANK VONTOBEL/CALL/YPSOMED N/340/0.02/20.12.24
Current month+2.42%
1 month+29.01%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
01/07/24 1.69 +2.42%
28/06/24 1.65 -2.37%
27/06/24 1.69 +2.42%
26/06/24 1.65 +17.86%
25/06/24 1.4 +2.19%

Delayed Quote Swiss Exchange

Last update July 01, 2024 at 04:20 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying YPSOMED HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WYPAJV
ISINCH1312989580
Date issued 09/01/2024
Strike 340 CHF
Maturity 20/12/2024 (172 Days)
Parity 50 : 1
Emission price 0.31 CHF
Emission volume N/A
Settlement physique
Currency CHF

Technical Indicators

Highest since issue 1.69 CHF
Lowest since issue 0.36 CHF
Delta0.81x
Omega 3.871
Premium3.46x
Gearing4.8x
Moneyness 1.210
Difference Strike -68 CHF
Difference Strike %-20.00%
Spread 0.05 CHF
Spread %2.87%
Theoretical value 1.715
Implied Volatility 41.87 %
Total Loss Probability 30.66 %
Intrinsic value 1.360
Present value 0.3550
Break even 425.75 CHF
Theta-0.01x
Vega0.02x
Rho0.02x

Company Profile

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
Sector
-
More about the company

Ratings for Ypsomed Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Ypsomed Holding AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
404 CHF
Average target price
378 CHF
Spread / Average Target
-6.44%
Consensus
  1. Stock Market
  2. Warrants
  3. WYPAJV Warrant